Equity Profile

MDLN

Medline Inc.

Health CareHealth Care Supplies$34.3B

Aug5Wed

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Medline Inc. is a major player in the health care supplies sector, providing a wide range of medical products and services....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will show how well Medline is managing costs and generating revenue.

N/A

Revenue Growth

Revenue growth will indicate how well the company is expanding its market share and responding to demand in the health care sector.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

MDLN Q2-2026 Earnings Preview

Context

Company Snapshot

Medline Inc. is a major player in the health care supplies sector, providing a wide range of medical products and services. With a market cap of $34 billion, the company is crucial for hospitals and healthcare providers, especially as demand for medical supplies continues to grow amid ongoing health challenges.

Earnings Scorecard·Last 2Q

EPS Beat Streak

EPS Beat Rate

50%

Avg EPS Surprise

-45.61%

Avg Stock Reaction

-5.46%

Last Quarter Recap

In Q1-2026, Medline reported an EPS of $0.33, beating estimates by 13%. However, the stock fell 7.30% the following day, indicating market skepticism despite the earnings beat.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations for Medline's upcoming earnings are mixed, with no analyst estimates available to guide predictions. Investors are looking for signs of sustained profitability and revenue growth.

Bull Case

If Medline can show strong revenue growth and maintain or improve its EPS, it could indicate a robust recovery and market confidence, potentially leading to a positive stock reaction.

Bear Case

Conversely, if the company fails to meet expectations for revenue or shows signs of declining margins, it could lead to further stock declines, especially given the recent negative market reaction.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

EPS is a critical measure of profitability, and a strong performance could reassure investors after the previous quarter's mixed results.

How is revenue growth trending in the current quarter?

Understanding revenue growth will help assess Medline's ability to capture market demand and sustain its business momentum.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Medline's ability to capitalize on increased demand for health care supplies, particularly in light of recent health trends.

Supporting Evidence

The options market is pricing in a 17.64% move, indicating expectations of volatility that may not align with historical performance.

Recent earnings history shows a mixed reaction, suggesting that the market may be overly cautious about Medline's growth potential.

Key Risk

If revenue growth exceeds expectations, it could significantly shift market sentiment in favor of Medline.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter, the focus will be on whether Medline can maintain profitability and grow revenue amid competitive pressures.

Bull Confirmed If

An EPS of $0.40 or higher would confirm the bull case, indicating strong profitability.

Bear Confirmed If

An EPS below $0.25 would support the bear case, suggesting ongoing challenges in profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±17.64%

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Detail

ATM IV

0.5%

30d HV

44.4%

Calls (41K)P/C Ratio: 0.13Puts (3K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Medline beats expectations, history suggests the stock could rise by around 5.46%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction as investors await further guidance.

Miss

A miss could lead to a decline of approximately 3.62%, reinforcing concerns about the company's performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on revenue growth trends in key segments.
2Management's commentary on cost management and margin stability.
3Insights into market demand for health care supplies.
4Any changes in guidance or outlook for the remainder of the fiscal year.
5Details on new product launches or innovations in the pipeline.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Medline Inc. is a major player in the health care supplies sector, providing a wide range of medical products and services....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will show how well Medline is managing costs and generating revenue.

N/A

Revenue Growth

Revenue growth will indicate how well the company is expanding its market share and responding to demand in the health care sector.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

MDLN Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 2Q

EPS Beat Streak

EPS Beat Rate

50%

Avg EPS Surprise

-45.61%

Avg Stock Reaction

-5.46%

Last Quarter Recap

In Q1-2026, Medline reported an EPS of $0.33, beating estimates by 13%. However, the stock fell 7.30% the following day, indicating market skepticism despite the earnings beat.

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Medline can show strong revenue growth and maintain or improve its EPS, it could indicate a robust recovery and market confidence, potentially leading to a positive stock reaction.

Bear Case

Conversely, if the company fails to meet expectations for revenue or shows signs of declining margins, it could lead to further stock declines, especially given the recent negative market reaction.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

EPS is a critical measure of profitability, and a strong performance could reassure investors after the previous quarter's mixed results.

How is revenue growth trending in the current quarter?

Understanding revenue growth will help assess Medline's ability to capture market demand and sustain its business momentum.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Medline's ability to capitalize on increased demand for health care supplies, particularly in light of recent health trends.

Supporting Evidence

The options market is pricing in a 17.64% move, indicating expectations of volatility that may not align with historical performance.

Recent earnings history shows a mixed reaction, suggesting that the market may be overly cautious about Medline's growth potential.

Key Risk

If revenue growth exceeds expectations, it could significantly shift market sentiment in favor of Medline.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter, the focus will be on whether Medline can maintain profitability and grow revenue amid competitive pressures.

Bull Confirmed If

An EPS of $0.40 or higher would confirm the bull case, indicating strong profitability.

Bear Confirmed If

An EPS below $0.25 would support the bear case, suggesting ongoing challenges in profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±17.64%

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Detail

ATM IV

0.5%

30d HV

44.4%

Calls (41K)P/C Ratio: 0.13Puts (3K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Medline beats expectations, history suggests the stock could rise by around 5.46%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction as investors await further guidance.

Miss

A miss could lead to a decline of approximately 3.62%, reinforcing concerns about the company's performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on revenue growth trends in key segments.
2Management's commentary on cost management and margin stability.
3Insights into market demand for health care supplies.
4Any changes in guidance or outlook for the remainder of the fiscal year.
5Details on new product launches or innovations in the pipeline.